earn icn pharmaceut report net incom fell 46 3 million second quarter end may 31 compar 5 6 million period year earlier revenu 9 44 5 million 40 7 million costa mesa base pharmaceut compani blame reduc earn partli higher research cost associ develop ribavirin compound use treat infant young children lower respiratori tract infect